Acron (MISX:AKRN) - Share price, News & Analysis

AKRN fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	1/6
Past Performance	4/6
Financial Health	4/6
Dividends	0/6

AKRN Stock Overview

Public Joint Stock Company Acron, together with its subsidiaries, manufactures, distributes, and sells chemical fertilizers and related mineral primary and by-products.

Rewards

Became profitable this year

Risk Analysis

Earnings are forecast to decline by an average of 16.2% per year for the next 3 years

Highly volatile share price over the past 3 months

Has a high level of debt

Acron Competitors

Saudi Basic Industries

SASE:2010

ر.س358.2b

OCI

ENXTAM:OCI

€7.8b

K+S

XTRA:SDF

€5.5b

Price History & Performance

Summary of all time highs, changes and price drops for Acron
Historical stock prices
Current Share Price	₽17,868.00
52 Week High	₽29,700.00
52 Week Low	₽5,736.00
Beta	-0.50
1 Month Change	-0.46%
3 Month Change	23.23%
1 Year Change	194.37%
3 Year Change	290.30%
5 Year Change	473.61%
Change since IPO	1,727.84%

Shareholder Returns

	AKRN	RU Chemicals	RU Market
7D	-4.6%	-2.1%	2.7%
1Y	194.4%	70.4%	-22.6%

Return vs Industry: AKRN exceeded the Russian Chemicals industry which returned 70.4% over the past year.

Return vs Market: AKRN exceeded the Russian Market which returned -22.6% over the past year.

Price Volatility

Is AKRN's price volatile compared to industry and market?
AKRN volatility
AKRN Average Weekly Movement	23.1%
Chemicals Industry Average Movement	15.3%
Market Average Movement	15.5%
10% most volatile stocks in RU Market	22.1%
10% least volatile stocks in RU Market	9.7%

Stable Share Price: AKRN is more volatile than 90% of Russian stocks over the past 3 months, typically moving +/- 23% a week.

Volatility Over Time: AKRN's weekly volatility has increased from 11% to 23% over the past year.

About the Company

Founded	Employees	CEO	Website
1992	n/a	Vladimir Kunitsky	https://www.acron.ru

Public Joint Stock Company Acron, together with its subsidiaries, manufactures, distributes, and sells chemical fertilizers and related mineral primary and by-products. The company provides mineral fertilizers, including complex and nitrogen fertilizers; organic compounds comprising methanol, formalin, urea-formaldehyde resins, melamine-urea-formaldehyde resins, and dipping resins; and non-organic compounds, such as low and high density ammonium nitrate, conversion calcium carbonate, liquid carbon dioxide, and urea for diesel exhaust fluid production. It also offers rare earth elements (REE) from apatite concentrate process flows consisting of cerium, lanthanum, neodymium, and didymium, as well as concentrates of light, medium, and heavy REE; and apatite concentrate and ammonia.

Acron Fundamentals Summary

How do Acron's earnings and revenue compare to its market cap?
AKRN fundamental statistics
Market Cap	₽656.78b
Earnings (TTM)	₽58.23b
Revenue (TTM)	₽170.99b

11.3x

P/E Ratio

3.8x

P/S Ratio

Is AKRN overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
AKRN income statement (TTM)
Revenue	₽170.99b
Cost of Revenue	₽68.40b
Gross Profit	₽102.59b
Other Expenses	₽44.36b
Earnings	₽58.23b

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)	1.58k
Gross Margin	60.00%
Net Profit Margin	34.06%
Debt/Equity Ratio	79.1%

How did AKRN perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

4%

Payout Ratio

Valuation

Is Acron undervalued compared to its fair value and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PEG Ratio
PB vs Industry

11.28x

Price to Earnings (PE) ratio

Share Price vs. Fair Value

Below Fair Value: AKRN (RUB17868) is trading above our estimate of fair value (RUB13082.31)

Significantly Below Fair Value: AKRN is trading above our estimate of fair value.

Price To Earnings Ratio

PE vs Industry: AKRN is poor value based on its PE Ratio (11.3x) compared to the Russian Chemicals industry average (7.4x).

PE vs Market: AKRN is poor value based on its PE Ratio (11.3x) compared to the Russian market (6.8x).

Price to Earnings Growth Ratio

PEG Ratio: AKRN's earnings are forecast to decline next year, so we can't calculate its PEG ratio.

Price to Book Ratio

PB vs Industry: AKRN is overvalued based on its PB Ratio (7.5x) compared to the RU Chemicals industry average (1.8x).

Future Growth

How is Acron forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

Future Growth Score

1/6

Future Growth Score 1/6

Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE

-16.2%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings vs Savings Rate: AKRN's earnings are forecast to decline over the next 3 years (-16.2% per year).

Earnings vs Market: AKRN's earnings are forecast to decline over the next 3 years (-16.2% per year).

High Growth Earnings: AKRN's earnings are forecast to decline over the next 3 years.

Revenue vs Market: AKRN's revenue is expected to decline over the next 3 years (-0.3% per year).

High Growth Revenue: AKRN's revenue is forecast to decline over the next 3 years (-0.3% per year).

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: AKRN's Return on Equity is forecast to be high in 3 years time (20%)

Past Performance

How has Acron performed over the past 5 years?

Past Performance Score

4/6

Past Performance Score 4/6

Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE

8.9%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: AKRN has high quality earnings.

Growing Profit Margin: AKRN became profitable in the past.

Past Earnings Growth Analysis

Earnings Trend: AKRN's earnings have grown by 8.9% per year over the past 5 years.

Accelerating Growth: AKRN has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: AKRN has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (53.1%).

Return on Equity

High ROE: AKRN's Return on Equity (51.6%) is considered outstanding.

Financial Health

How is Acron's financial position?

Financial Health Score

4/6

Financial Health Score 4/6

Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage

Financial Position Analysis

Short Term Liabilities: AKRN's short term assets (RUB58.8B) exceed its short term liabilities (RUB29.6B).

Long Term Liabilities: AKRN's short term assets (RUB58.8B) do not cover its long term liabilities (RUB97.4B).

Debt to Equity History and Analysis

Debt Level: AKRN's net debt to equity ratio (64.8%) is considered high.

Reducing Debt: AKRN's debt to equity ratio has reduced from 92.3% to 79.1% over the past 5 years.

Debt Coverage: AKRN's debt is well covered by operating cash flow (64.8%).

Interest Coverage: AKRN's interest payments on its debt are well covered by EBIT (22.6x coverage).

Balance Sheet

Dividend

What is Acron current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage

0.34%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: AKRN's dividend (0.34%) isn’t notable compared to the bottom 25% of dividend payers in the Russian market (3.8%).

High Dividend: AKRN's dividend (0.34%) is low compared to the top 25% of dividend payers in the Russian market (11.02%).

Stability and Growth of Payments

Stable Dividend: AKRN is not paying a notable dividend for the Russian market, therefore no need to check if payments are stable.

Growing Dividend: AKRN is not paying a notable dividend for the Russian market, therefore no need to check if payments are increasing.

Earnings Payout to Shareholders

Earnings Coverage: AKRN is not paying a notable dividend for the Russian market.

Cash Payout to Shareholders

Cash Flow Coverage: AKRN is not paying a notable dividend for the Russian market.

Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

12.1yrs

Average management tenure

CEO

Vladimir Kunitsky (73 yo)

17.33yrs

Tenure

Mr. Vladimir Yakovlevich Kunitsky has been the Chairman of the Managing Board and Chief Executive Officer of Public PJSC Acron (formerly known as Public Joint Stock Company Acron (formerly known as Joint S...

Leadership Team

Experienced Management: AKRN's management team is seasoned and experienced (12.1 years average tenure).

Board Members

Experienced Board: AKRN's board of directors are considered experienced (7 years average tenure).

Ownership

Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Data	Last Updated (UTC time)
Company Analysis	2022/05/22 00:00
End of Day Share Price	2022/05/20 00:00
Earnings	2021/09/30
Annual Earnings	2020/12/31